Resource Center: Induction and dosing, Becoming waivered

5 results

Search Results

Substance Abuse & Mental Health Services Administration
Description: 
The Substance Abuse and Mental Health Services Administration (SAMHSA) provides this website so that physicians can improve the deliver and financing of prevention, treatment and recovery support services to patients.
Source: 
Substance Abuse and Mental Health Services Administration (SAMHSA)
0
Your rating: None
Tags:
Drug Safety Information for Providers and Patients: Buprenorphine tablets
Description: 
Buprenorphine tablets are approved for the treatment of opiate dependence. Buprenorphine treats opiate addiction by preventing symptoms of withdrawal from heroin and other opiates.
Source: 
Food and Drug Administration (FDA)
0
Your rating: None
Tags:
PCSS-B Guidance: Buprenorphine Induction
Description: 
This document discusses the logistics of successful buprenorphine induction, offering insight into clinical questions that should be addressed, the goal of induction, general principles, and recommendations based on low and high levels of evidence. Recommendations are included for both in-office and at-home inductions.
Source: 
Physician Clinical Support System (PCSS)
4
Your rating: None Average: 4 (2 votes)
Tags:
Supplemental Case Studies
Description: 
These case studies are intended to serve as a supplement to the buprenorphine training. Areas covered include: patient assessment, induction, and maintenance. These cases can be used free of charge.
Source: 
Clinical Tools, Inc.
4.666665
Your rating: None Average: 4.7 (3 votes)
Tags:
Clinical Use of Buprenorphine
Description: 
This CME course instructs physicians on some subtleties of buprenorphine treatment that can minimize the risk of the patient being harmed either by an adverse drug effect or by relapsing to opioid abuse.
Source: 
Clinical Tools, Inc.
4.333335
Your rating: None Average: 4.3 (3 votes)
Tags: